UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 20, 2007
OraSure Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware | 001-16537 | 36-4370966 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
220 East First Street Bethlehem, Pennsylvania |
18015-1360 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: 610-882-1820
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry Into a Material Agreement.
OraSure Technologies, Inc. (the Company) and SSL International plc (SSL) are parties to a Distribution Agreement, dated as of June 1, 2005, as amended (the Original Distribution Agreement), pursuant to which the Company supplies to SSL, and SSL distributes in certain foreign countries, an over-the-counter product for the cryosurgical removal of common and plantar warts (the Product).
On December 20, 2007, the Company and SSL entered into Amendment No. 2 to Distribution Agreement, dated as of November 30, 2007 (the Amendment). The purpose of the Amendment was to amend the Original Distribution Agreement to, among other things, (i) adjust Product pricing and establish purchase minimums for 2008, (ii) provide for the reimbursement by the Company of a portion of SSLs advertising and promotional expenses for the Product during 2008, (iii) revise the Product specifications, and (iv) establish a process for modifying and extending the term of the Original Distribution Agreement for years beyond 2008.
Signatures
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
ORASURE TECHNOLOGIES, INC. | ||||
Date: December 21, 2007 | By: | /s/ Jack E. Jerrett | ||
Jack E. Jerrett | ||||
Senior Vice President, General Counsel and Secretary |